aTYR PHARMA INC
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-48.2M | $-57.9M | $-48.0M | $-24.4M | $-20.0M |
| Depreciation & Amortization | $713.0K | $900.0K | $869.0K | $829.0K | $714.0K |
| Depreciation | — | — | — | — | — |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Net Cash from Operating Activities | $-42.4M | $-52.9M | $-36.8M | $-22.8M | $-17.3M |
| Investing Activities | |||||
| Capital Expenditures | $1.3M | $600.0K | $664.0K | $249.0K | $644.0K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-27.6M | $33.5M | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $52.7M | $4.7M | — | — | — |
| Net Change in Cash | $-17.3M | $-14.6M | $39.1M | $-22.6M | $32.8M |
| Free Cash Flow | $-43.7M | $-53.5M | $-37.5M | $-23.1M | $-18.0M |